CliffBio
small molecule

PATADAY ONCE DAILY RELIEF

OLOPATADINE HYDROCHLORIDE

Loss of exclusivityMay 2032latest FDA-listed patent expiry
CompanyAlcon →See this company's full patent-cliff portfolio

Drug detail

Brand namePATADAY ONCE DAILY RELIEF
Active ingredientOLOPATADINE HYDROCHLORIDE
StrengthEQ 0.7% BASE
Dosage formSOLUTION/DROPS
RouteOPHTHALMIC
ModalitySmall molecule
FDA approvalJanuary 2015
Marketing statusOTC

Listed patents

PatentExpiresType
8791154May 2032product
9533053May 2032product

More from Alcon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

PATADAY ONCE DAILY RELIEF patent cliff — loss of exclusivity May 2032 | CliffBio